Combivir
Product Images NDC 16590-061

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Combivir (NDC 16590-061). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Combivir150 300mg Label)

Combivir 150 mg/300 mg tablet bottle label from Stat Rx USA, containing 30 tablets. The label specifies the generic components lamivudine 150 mg and zidovudine 300 mg, with NDC 16590-061-30. It includes manufacturing and lot sample details, cautionary statements about drowsiness or dizziness, and storage instructions.*

FDA Label Image

Structure Image 1 (Lamivudine Structure)

Chemical structure of the active ingredient depicted in the image, showing a heterocyclic base with nitrogen and oxygen atoms attached to a sugar-like ring containing sulfur and hydroxyl groups.*

FDA Label Image

Structure Image 2 (Zidovudine Structure)

Chemical structure diagram of the active ingredient in Combivir, showing a nucleoside analog with azido and hydroxymethyl functional groups attached to the sugar ring and a methylated pyrimidine base.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.